Prevention of Progression in Diabetic Nephropathy

Prevention of Progression in Diabetic Nephropathy Phillip M. Hall , MD Abstract In Brief Diabetic nephropathy is the most common cause for end-stage renal disease and for patients entering into chronic dialysis care. It occurs in 25–40% of patients with diabetes. Risk factors include hyperglycemia,...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes spectrum 2006-01, Vol.19 (1), p.18-24
1. Verfasser: Hall, Phillip M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Prevention of Progression in Diabetic Nephropathy Phillip M. Hall , MD Abstract In Brief Diabetic nephropathy is the most common cause for end-stage renal disease and for patients entering into chronic dialysis care. It occurs in 25–40% of patients with diabetes. Risk factors include hyperglycemia, hypertension, genetic predisposition, glomerular hyperfiltration, proteinuria, the renal renin-angiotensin system, advanced glycation end-products, and possibly reduced nephron number and lipid disorders. Prevention of diabetic nephropathy is crucial. Tight control of diabetes, blood pressure treatment to systolic pressure of < 130 mmHg, reduction of proteinuria, and treatment with drugs that inhibit the renin-angiotensin system are all associated with prevention of or delay in progression of diabetic kidney injury. Footnotes Phillip M. Hall, MD, is a consultant in the Department of Nephrology and Hypertension at the Cleveland Clinic Foundation in Cleveland, Ohio. American Diabetes Association
ISSN:1040-9165
1944-7353
DOI:10.2337/diaspect.19.1.18